IGMS
Price
$1.27
Change
-$0.03 (-2.31%)
Updated
Aug 13 closing price
Capitalization
76.57M
One day until earnings call
THRD
Price
$5.38
Change
-$0.01 (-0.19%)
Updated
Jul 30 closing price
Capitalization
242.79M
81 days until earnings call
Interact to see
Advertisement

IGMS vs THRD

Header iconIGMS vs THRD Comparison
Open Charts IGMS vs THRDBanner chart's image
IGM Biosciences
Price$1.27
Change-$0.03 (-2.31%)
Volume$1.62M
Capitalization76.57M
Third Harmonic Bio
Price$5.38
Change-$0.01 (-0.19%)
Volume$1.42M
Capitalization242.79M
IGMS vs THRD Comparison Chart in %
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. THRD commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a Hold and THRD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (IGMS: $1.27 vs. THRD: $5.38)
Brand notoriety: IGMS and THRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 204% vs. THRD: 258%
Market capitalization -- IGMS: $76.57M vs. THRD: $242.79M
IGMS [@Biotechnology] is valued at $76.57M. THRD’s [@Biotechnology] market capitalization is $242.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 1 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • IGMS’s FA Score: 1 green, 4 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, THRD is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 2 TA indicator(s) are bullish while THRD’s TA Score has 4 bullish TA indicator(s).

  • IGMS’s TA Score: 2 bullish, 5 bearish.
  • THRD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, THRD is a better buy in the short-term than IGMS.

Price Growth

IGMS (@Biotechnology) experienced а 0.00% price change this week, while THRD (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

IGMS is expected to report earnings on Aug 18, 2025.

THRD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
THRD($243M) has a higher market cap than IGMS($76.6M). THRD YTD gains are higher at: -47.716 vs. IGMS (-79.214). IGMS has higher annual earnings (EBITDA): -702K vs. THRD (-66.25M). THRD has more cash in the bank: 272M vs. IGMS (104M). IGMS has less debt than THRD: IGMS (0) vs THRD (3M). IGMS has higher revenues than THRD: IGMS (145M) vs THRD (0).
IGMSTHRDIGMS / THRD
Capitalization76.6M243M32%
EBITDA-702K-66.25M1%
Gain YTD-79.214-47.716166%
P/E RatioN/AN/A-
Revenue145M0-
Total Cash104M272M38%
Total Debt03M-
FUNDAMENTALS RATINGS
IGMS: Fundamental Ratings
IGMS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IGMSTHRD
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 24 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVVC0.05N/A
N/A
Firsthand Technology Value Fund, Inc.
DCOHF0.63N/A
N/A
Dickson Concepts International Ltd.
MIESY10.10N/A
N/A
Mitsui E&S Co Ltd.
MACT8.00N/A
N/A
MachTen, Inc.
PTAIY6.44N/A
N/A
PT Astra International

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
N/A
MRSN - IGMS
53%
Loosely correlated
-3.50%
CRNX - IGMS
47%
Loosely correlated
+3.47%
DYN - IGMS
45%
Loosely correlated
-0.96%
MDGL - IGMS
42%
Loosely correlated
-0.41%
APGE - IGMS
39%
Loosely correlated
-2.18%
More

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with NVAX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then NVAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
N/A
NVAX - THRD
42%
Loosely correlated
+1.59%
IGMS - THRD
40%
Loosely correlated
N/A
APGE - THRD
38%
Loosely correlated
-2.18%
ACLX - THRD
34%
Loosely correlated
+3.09%
ADMA - THRD
34%
Loosely correlated
+0.12%
More